Should immunonutrition become routine in critically ill patients? A systematic review of the evidence.

By D. Heyland, F. Novák, J. Drover, Minto K Jain, Xiang-Qian Su, U. Suchner. Journal of the American Medical Association (JAMA), 2001

880 citations recorded by the source corpus.

Subfields: Nutrition and Dietetics, Physiology, Surgery

View Paper: https://www.semanticscholar.org/paper/6eec91edb2d4baeb66d1bc44fc36aa8457974d01

How researchers see this paper

The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.

In Nutrition and Dietetics

1. Todd W. Rice

In Surgery

1. D. Heyland
2. R. Dhaliwal

Citations in the corpus

• Canadian clinical practice guidelines for nutrition support in mechanically ventilated, critically ill adult patients. (2003, background): “Recent review papers have documented that nutrition support does influence morbidity and mortality in critically ill patients.(3,6,12) Therefore, strategies to improve the delivery of nutrition support are relevant and may result in decreased morbidity and mortality.”
• Guidelines for the Provision and Assessment of Nutrition Support Therapy in the Adult Critically Ill Patient: Society of Critical Care Medicine (SCCM) and American Society for Parenteral and Enteral Nutrition (A.S.P.E.N.) (2009, background): “[Quality of Evidence: Very Low] Rationale: In selecting immune-modulating enteral formulations (supplemented with arginine, EPA, DHA, glutamine, and nucleic acid) for the critically ill patient, the clinician must first decide if the patient is a candidate for a specialty immunemodulating formulatio”
• Glutamine supplementation in serious illness: A systematic review of the evidence* (2002, methodology): “First, we considered that the treatment effect may be different in surgical patients compared with critically ill patients, as has been demonstrated in previous analyses (32, 33).”
• Guidelines for the Provision and Assessment of Nutrition Support Therapy in the Adult Critically Ill Patient: Society of Critical Care Medicine (SCCM) and American Society for Parenteral and Enteral Nutrition (A.S.P.E.N.). (2009, background): “[Quality of Evidence: Very Low] Rationale: In selecting immune-modulating enteral formulations (supplemented with arginine, EPA, DHA, glutamine, and nucleic acid) for the critically ill patient, the clinician must first decide if the patient is a candidate for a specialty immunemodulating formulatio”
• ESPEN Guidelines on Parenteral Nutrition: intensive care. (2006, neutral): “Of these, only the meta-analysis by Heyland et al.(45) and the reviews by Montejo and Nitenberg differentiated between elective surgical and critically ill patients.”